Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Enzyme reins in runaway inflammation; May prove potent drug target

30.08.2004


An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered. The discovery in research with mice suggests a promising target for treating a range of inflammatory diseases in which the body’s immune reaction to bacterial invasion spirals out of control, the researchers report.



The enzyme, known as A20, controls the first step in the series of signals that unleash immune system soldiers against a foreign microbe, the scientists found. The enzyme’s action, they discovered, blocks signals from pivotal receptors on immune cells, known as toll-like receptors (TLRs), that directly sense the presence of dangerous bacteria and other microbes.

The research shows that A20 prevents over-reactions of the immune system to blood infections known as sepsis -- a life-threatening condition in which bacteria invade the bloodstream. Unchecked by A20, the new research shows, an over-reactive immune response can lead to a deadly collapse of blood pressure. Because bacteria are plentiful in our intestines, the protein may also control the immune reaction that can cause inflammatory bowel disease, the research shows.


Discovery of the ubiquitous enzyme’s role in shutting down rampant inflammation is being published online August 29 by Nature Immunology.

The research adds to earlier work by the UCSF scientists and colleagues, published in Science, showing that A20 blocks signals triggered by one of the major agents of inflammation -- the immune system’s tumor necrosis factor (TNF). In the new study, the scientists found that mice lacking genes for both the A20 enzyme and TNF still exhibited a high level of inflammation, indicating that the anti-inflammation protection afforded by A20 is at least in part independent of TNF.

"Finding one enzyme that can rein in two potent pathways of inflammation increases the potential benefits of developing drugs to enhance or restore A20’ s effectiveness," said Averil Ma, MD, Rainin Distinguished Professor of Medicine at UCSF and senior author on the Nature Immunology paper.

In addition to restricting inflammation, A20 may also protect tissues from the damage inflammation can cause, Ma said. His group found that A20 protects cells from "programmed cell death," a process by which cells near the site of inflammation may be killed. Many autoimmune diseases such as type 1 diabetes and arthritis involve cell death and damage to tissues caused by programmed cell death, and A20 may naturally prevent this damage, Ma said.

Finally, mounting evidence has linked subtle and chronic states of inflammation with atherosclerosis, the process by which arteries become clogged and lead to heart attacks and strokes. The A20 enzyme may also be a good target to treat these diseases, Ma said.

"Finding that A20 may control multiple important inflammatory processes provides an extremely attractive model -- a lesson from nature -- showing how one might use a single protein to have multiple therapeutic benefits," Ma said. "A drug that mimicked A20’s sundry functions could be extraordinarily useful."

A20 controls inflammation by blocking the immune system’s first line of defense against bacterial attack. When bacteria invade, their carbohydrates bind to TLRs on the surface of macrophages and other immune cells. This initiates a chain reaction of signals in which proteins inside the macrophages are modified. The end result: the macrophages produce and secrete tumor necrosis factor (TNF), interleukin-1 and other cytokines that induce inflammation.

The researchers showed that A20 shuts down one of these signaling proteins, called TRAF6, turning off the immune system cascade. The enzyme, they found, disables the signaling molecule by cleaving off from it a small protein called ubiquitin which would normally activate the signaling molecule.

Recent studies have suggested that ubiquitin modifications may be very important for regulating a wide variety of inflammatory signals within cells. The new research, along with a study by Ma and colleagues published online July 18 by Nature, shows that A20 modifies ubiquitin-containing proteins in two ways, both to deactivate the proteins and remove them.

Wallace Ravven | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Life Sciences:

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>